Core Viewpoint - The transformation of Beijing Tongrentang's Daxing Plant into a digital intelligent manufacturing facility represents a significant step towards modernizing traditional Chinese medicine production, enhancing efficiency and quality through advanced technology [1][6][8] Group 1: Digital Transformation - The Daxing Plant has completed the digitalization of its production lines, enabling real-time monitoring and management of production processes [2][4] - The plant's intelligent monitoring platform allows for integrated management of production data, addressing issues of data fragmentation and improving overall production efficiency [2][3] - The transition from single production line digitalization to a comprehensive digital intelligent workshop is underway, aiming to connect and utilize data across the entire facility [4][5] Group 2: Production Efficiency - The Daxing Plant's digital upgrades do not directly increase the capacity of individual machines but optimize the overall production path through coordinated operations [3][5] - Real-time data collection and analysis are being implemented to enhance product quality and standardization, contributing to higher overall yield rates [2][5] - The plant's management can now make more informed decisions through access to multi-dimensional production reports and visual analysis models [3][7] Group 3: Future Plans and Goals - The Daxing Plant aims to establish a model for digital intelligent transformation in traditional Chinese medicine manufacturing, with plans for further data integration and system upgrades across all production bases [6][7] - The company has set higher expectations for its digital transformation, focusing on the standardization of production data and the integration of technology with industry [7][8] - The long-term vision includes optimizing production processes through accumulated data, ultimately achieving the goal of an intelligent factory [5][6]

Core Viewpoint - Innovation and adherence are essential for long-term stability in the pharmaceutical industry, with Kangyuan Pharmaceutical leveraging innovation as its core driving force and showcasing resilience and potential in a competitive market [2]. Group 1: Intelligent Manufacturing - Intelligent manufacturing is the key carrier for transforming innovation into core competitiveness for Kangyuan Pharmaceutical, addressing challenges in traditional Chinese medicine production such as standardization and traceability [3]. - The company has embraced the "digital + intelligent" revolution, reconstructing the entire production process of traditional Chinese medicine with advanced technology [3]. - Kangyuan has developed a knowledge system (PKS) based on big data, which acts as the "smart brain" for intelligent production, optimizing process parameters to ensure product quality [3]. Group 2: Research and Development Foundation - The intelligent manufacturing capabilities of Kangyuan are rooted in continuous high-intensity R&D investment and a strong research foundation [4]. - The company engages in significant national research projects, translating research outcomes into intelligent production capabilities [4]. - A virtuous cycle is formed between R&D and intelligent manufacturing, where R&D provides theoretical support and manufacturing offers a platform for rapid and precise conversion of research results [4]. Group 3: Future Outlook - Kangyuan Pharmaceutical aims to deepen its innovation-driven strategy, modernizing and upgrading the entire Chinese medicine industry while contributing to human health with superior solutions [4].